Translational Oncology
Q1 Journal
Open Access
Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Oncology
Q1
└
Cancer Research
Q2
Publisher
SJR 2025
1.383
Q1
SJR Score
H-Index
84
Citations / Doc (2yr)
5.03
Total Docs. (latest)
405
Total Citations (3yr)
4,301
Publication type
Journals
ISSN
19447124, 19365233
Coverage
2008-2026
Journal Rank
#2,820
Subject Categories
Oncology
Q1
Cancer Research
Q2
Subject Areas
Aims & Scope
Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients.
Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer.
Peer reviewed manuscript types include Original Reports, Reviews and Editorials.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Embase
Detailed Metrics
| Total Docs. (latest) | 405 |
| Total Docs. (3 years) | 876 |
| Total Refs. | 21,847 |
| Total Citations (3 years) | 4,301 |
| Citable Docs. (3 years) | 865 |
| Citations / Doc. (2 years) | 5.03 |
| Ref. / Doc. | 53.94 |
| % Female | 44.9% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.